“Fat burner” and “weight loss peptide” get used as if they were the same kind of product. They are not. One is a marketing label for a shelf of stimulant and herbal supplements. The other, in practice, mostly means the GLP-1 family of compounds, which have some of the strongest weight-loss data in medicine. Here is what each one is, what the trials found, and what that means if you are weighing them up.
Fat burners vs peptides in 60 seconds
- Fat burners are usually caffeine, green tea extract and similar stimulants. The best reviews find small effects at most.
- GLP-1 peptides (semaglutide, tirzepatide, retatrutide) work mainly on appetite. In trials they produced average weight loss of roughly 15 to 24 percent of body weight.
- Other fat-loss peptides such as AOD-9604 have far weaker human evidence than the GLP-1s.
- Stimulant fat burners and some peptides do not mix well. If you are researching a GLP-1, skip the stimulants.
What a fat burner actually is
“Fat burner” is not a drug class. It is a product category, and the label covers whatever a brand decides to put in the tub. Most formulas are built from a handful of ingredients: caffeine, green tea extract, bitter orange (synephrine), capsaicin, L-carnitine and yohimbine. The pitch is that they raise energy use slightly and take the edge off appetite.
The most useful evidence we have is from reviews of the individual ingredients rather than the branded blends. A Cochrane review of green tea preparations for weight loss, covering trials of 12 weeks or more in overweight and obese adults, found no meaningful difference in the studies run outside Japan: an average of 0.04 kg, with a confidence interval running from a loss of 0.5 kg to a gain of 0.4 kg. The Japanese trials were not comparable enough to pool, and showed a wide spread from almost nothing up to a few kilograms.
The best-studied stimulant ever sold for this purpose was ephedra. A JAMA review of the trials found it produced about 0.9 kg a month more weight loss than placebo, over periods of up to six months, and it was also associated with a 2.2 to 3.6 times higher chance of psychiatric, autonomic or gastrointestinal symptoms, including heart palpitations. That is roughly the ceiling for what a stimulant can do, and the price paid for it. Ephedra has since been restricted in many countries for exactly that reason.
What “peptides for weight loss” usually means
When people search for weight loss peptides they almost always mean the GLP-1 family: semaglutide, tirzepatide and retatrutide. These mimic gut hormones that tell the brain you are full, slow stomach emptying and affect how the body handles glucose. They do not “burn” fat directly. They change appetite so that eating less stops feeling like a fight, which is why the weight comes off.
The trial results are not in the same league as supplements:
- Semaglutide (STEP 1, 68 weeks): average weight change of 14.9 percent, against 2.4 percent on placebo.
- Tirzepatide (SURMOUNT-1, 72 weeks): 15.0, 19.5 and 20.9 percent at the three doses tested, against 3.1 percent on placebo.
- Retatrutide (phase 2, 48 weeks): up to 24.2 percent at the highest dose tested, against 2.1 percent on placebo. This was a phase 2 trial of 338 people, so it is early data.
Our guides to how the three compare and brand names versus the underlying molecules go further into the differences.
The other fat-loss peptides
There is a third group that sits between the two: compounds such as AOD-9604, 5-Amino-1MQ, SLU-PP-332 and MOTS-c, which are sold on the idea of changing how the body burns and stores energy. The human evidence here is much thinner than for the GLP-1s. AOD-9604 in particular did not show meaningful weight loss in its human trials. We cover each one in fat-loss peptides that are not GLP-1s.
Side by side
| Fat burners | GLP-1 peptides | Other fat-loss peptides | |
|---|---|---|---|
| How they work | Stimulants and herbal extracts, mild effect on energy use and appetite | Mimic gut hormones, reduce appetite and slow stomach emptying | Proposed effects on fat metabolism and mitochondria |
| Best human evidence | Reviews of caffeine, green tea and ephedra: small, short-term effects | Large randomised trials of 68 to 72 weeks | Small human studies or animal data only |
| Size of effect | Under 1 kg a month at best (ephedra); close to zero for green tea | Roughly 15 to 24 percent of body weight in trials | Not established in people |
| Main downsides | Racing heart, jitters, poor sleep, raised blood pressure | Nausea, constipation and other gut effects, usually worst while the dose is stepped up | Unknown, because the human data is limited |
| Status | Sold as supplements | Semaglutide and tirzepatide are prescription medicines; the research compounds we supply are for research use only | Research use only |
Can you use both?
Our honest answer is that you probably should not. GLP-1 compounds already tend to raise resting heart rate in the trials, and stimulant fat burners do the same. Stacking the two adds load to the cardiovascular system for a benefit nobody has measured. Nausea and a reduced appetite also make it harder to tolerate high-caffeine products. We go through what is and is not worth adding in how to get more from retatrutide. If you take any medicine or have a heart condition, speak to your doctor first.
What does most of the work either way
Neither category replaces the basics. Enough protein and resistance training protect muscle while weight comes down, and sleep drives appetite more than most people expect. If you are tracking progress, measuring body composition tells you far more than the scale does, because losing weight and losing fat are not the same thing.
Questions people ask
Do fat burners work?
Modestly at best. A Cochrane review found no meaningful effect from green tea preparations on weight, and the strongest stimulant ever studied, ephedra, produced under 1 kg a month more than placebo in short trials, with more palpitations and other side effects.
Are peptides fat burners?
Not in the usual sense. The GLP-1 peptides mainly reduce appetite rather than burning fat directly. A few other compounds are studied for fat metabolism, but the human evidence for them is much weaker.
Can I take a fat burner with a GLP-1 peptide?
We would not. Both can raise heart rate, so combining them adds strain without a proven benefit. Speak to a doctor, especially if you have a heart condition or take other medicine.
Which is better for weight loss, a fat burner or a peptide?
On the evidence, the GLP-1 peptides are far stronger than any fat burner, with average losses of 15 percent or more of body weight in trials. They also carry real side effects and are not a substitute for food, training and sleep. Registered versions are prescription medicines.
Is it legal to buy weight loss peptides in South Africa?
We supply research compounds for research use only, not registered medicines. Our guide on whether peptides are legal in South Africa explains the position in detail.
Sources
- Jurgens TM, et al. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database of Systematic Reviews 2012.
- Shekelle PG, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. JAMA 2003;289(12):1537-1545.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216.
- Jastreboff AM, et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med 2023;389:514-526.
This article is for educational purposes only and is not medical advice. Fat burners are supplements and the peptides we supply are sold for research use only; none of them is a registered medicine in South Africa through us.
For the full picture on the appetite side, see our peptides for weight loss guide. New to the topic? What are peptides is the place to start.

